Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinylases

Dakshinamurthy Sivakumar1, Vikash Kumar1,2, Michael Naumann2

  • 1Max Planck Institute for Dynamics of Complex Technical Systems, Molecular Simulations and Design Group, 39106 Magdeburg, Germany.

Insights

Ovarian tumor domain deubiquitinylating enzymes OTUB1 and OTUB2 show distinct catalytic site configurations and water accessibility. These differences in ovarian tumor domain ubiquitin aldehyde binding 1 and 2 may guide selective inhibitor design for cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Ovarian tumor domain (OTU) deubiquitinylating proteases, specifically OTUB1 and OTUB2, are key regulators of cellular processes like apoptosis and signaling.
  • Elevated expression of OTUB proteins is linked to various cancers, including ovarian, breast, and endometrial cancers, highlighting their oncogenic potential.

Purpose of the Study:

  • To investigate the structural and dynamic differences between OTUB1 and OTUB2 using molecular dynamics simulations.
  • To elucidate the mechanisms underlying the catalytic activity and substrate accessibility of OTUB1 and OTUB2.
  • To identify potential targets for the selective design of OTU-based inhibitors for cancer treatment.

Main Methods:

  • Molecular dynamics (MD) simulations were employed to analyze the catalytic triad configuration, protonation states, and water accessibility of OTUB1 and OTUB2.
  • Analysis of active-site residue interactions and water diffusion trajectories was performed.

Main Results:

  • Both OTUB1 and OTUB2 possess a catalytic triad characteristic of proteases, but with distinct configurations and protonation states.
  • OTUB1 features a prearranged catalytic site, while OTUB2 requires ubiquitin binding for catalytic triad rearrangement into an active conformation.
  • OTUB2 exhibits greater solvent accessibility to its catalytic site compared to OTUB1, with a stable hydrogen bond between His224 and Asn226.

Conclusions:

  • The observed differences in activation kinetics, protonation states, water channels, and active-site accessibility between OTUB1 and OTUB2 are significant.
  • These mechanistic distinctions provide a basis for the rational and selective design of OTU inhibitors targeting specific deubiquitinylases in cancer therapy.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.6K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.5K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.5K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.9K
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
1.5K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.8K